Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.900
+0.200 (11.76%)
Apr 29, 2025, 2:07 PM EDT - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.05 million as of April 29, 2025. Its market cap has decreased by -40.77% in one year.
Market Cap
1.05M
Enterprise Value
-3.05M
1-Year Change
-40.77%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.05M, a decrease of -98.44%. That is a compound annual growth rate of -69.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 941.82K | -64.03% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |